Anaesthesia devices are those devices that are used mainly during surgeries to induce coma. They provide an appropriate and uninterrupted supply of medical gases mixed with anaesthetic vapour which serves the purpose of an induced coma. The application of anaesthesia in patients results in loss of sensation or awareness.  Anaesthesia devices can control conditions like pain, breathing, blood flow, blood pressure, and heart rate. Respiratory devices aid in improving pulmonary functions by eliminating mucus from the respiratory airways. They are mainly used in the diagnosis and treatment of respiratory diseases like chronic obstructive pulmonary disease (COPD), asthma, tuberculosis, pneumonia, and others. Respiratory devices are leading the market when compared to anaesthesia devices because of their wide usage and the limited usage of anaesthetic devices due to limited number of end-users. Initially, anaesthesia and respiratory devices were developed for operating purposes only. However, rising awareness amongst people and technological advancements have enabled the usage of these devices in post-operative care units, delivery rooms, and critical care units and enhanced their market demand. The Anaesthesia and Respiratory Devices Market valued 32.3 billion USD in 2020 and is expected to reach 66.0 billion USD by 2030 with the CAGR of 7.4% during the forecast period.

Market Segmentation:

On the basis of product type, the anaesthesia and respiratory devices market can be segmented into anaesthesia machines, anaesthesia disposables, respiratory machines, respiratory measurement devices, and respiratory disposables. Anaesthesia machines can be further segmented into delivery machines, monitors, ventilators, and workstations. The delivery machines can be again bifurcated into portable and standalone delivery machines. The anaesthesia disposables can be further segregated into disposable masks and disposable accessories. The respiratory machines can be classified into equipment, ventilators, nebulizers, humidifiers, inhalers, oxygen concentrators, and reusable resuscitators. The equipment can be further classified into bi-level positive airway devices and continuous positive airway devices. The ventilators are again classified into adult ventilators and neonatal ventilators. The nebulizers are further segregated into pneumatic nebulizers, mesh nebulizers, and ultrasonic nebulizers. The humidifiers are further categorised into heat humidifiers, heated wire breathing circuits, heat exchangers, and pass over humidifiers. The inhalers are further bifurcated into dry powered inhalers and metered dose inhalers. The oxygen concentrators are further segregated into fixed oxygen concentrators and portable oxygen concentrators. The respiratory measurement devices are categorised into pulse oximeters, capnographs, spirometers, and peak flow meters. The respiratory disposables are classified into disposable oxygen masks, resuscitators, tracheostomy tubes, and oxygen cannula. On the basis of end user, the market is divided into hospitals, ambulatory service centers, homecare, and clinics. Geographically, the global anaesthesia and respiratory devices market can be broadly divided into five regions mainly North America, Europe, Asia Pacific, and ROW.

Market Dynamics and Factors:

The growing geriatric population in developed and developing countries, increasing tobacco consumption resulting in occurrence of chronic respiratory diseases; rising number of surgeries; increased healthcare expenditure; and rising demand in home healthcare. These factors contribute significantly towards the growth of anaesthesia and respiratory devices market. Furthermore, rapid urbanisation and industrialisation has led to the rise in the air pollution levels which further leads to chronic respiratory diseases and enhances the market growth of anaesthesia and respiratory devices. For instance, according to World Health Organisation in 2016, around 251 million cases of chronic obstructive pulmonary disorder (COPD) were reported. Technological advancements and rising innovations in the development of anaesthesia and respiratory devices are going to fuel the market growth in the near future. For instance, B. Braun Medical Inc. made an announcement of introducing Clorotekal, which is a U.S Food & Drug Administration approved anaesthetics for spinal anaesthesia. However, certain factors like high costs involved in the installation and maintenance of anaesthesia and respiratory devices; stringent regulations for the adoption of anaesthetic devices; and low adoption rate in underdeveloped economies are restraining the growth of the anaesthesia and respiratory devices market.

Geographic Analysis:

North America is expected to dominate the global anaesthesia and respiratory devices market in the forecast period in terms of market share. Factors such as rising geriatric population; growing healthcare expenditure; high adoption rate of technologically advanced devices; and increasing investments of major players of the anaesthesia & respiratory devices market are the key factors attributing to the market dominance of the region. For instance, almost 12 million people in the U.S suffer from COPD. The Asia Pacific region is expected to witness maximum growth during the forecast period. Major countries like China, Japan, and India are going to be key contributors for the market growth of anaesthesia and respiratory devices in the APAC region. For instance, according to the International Journal of Pulmonary and Respiratory Sciences in 2016, COPD is the second largest cause of death in India.   

Competitive Scenario:

The key players operating in the global anaesthesia and respiratory devices market are –

GE Healthcare, Philips Healthcare, Covidien, Teleflex Inc., Pfizer, Johnson & Johnson, Draegerwerk AG, AstraZeneca, Hamilton Medical AG, Invacare Corporation, Masimo Corporation, Dickson & Company.      

Anaesthesia And Respiratory Devices Market Report Scope